Table 1.
In vitro evaluation of LSD1 inhibition by the LSD1 inhibitor 1 a, prodrugs 1 b–g and negative controls 2 a, 2 c and 2 f using a Peroxidase‐coupled assay. Most of the prodrugs are >100 times less potent than parent drug 1 a. Determination of higher IC50 values were not possible due to poor solubility. n.i.=inhibition≤10 %.
|
# |
LSD1 inhibition in vitro IC50 [μM] |
Potency window prodrug/1 a |
---|---|---|---|
LSD1 inhibitor |
1 a |
0.094±0.017 |
|
prodrugs |
1 b |
n.i. at 10 μM |
>110 |
1 c |
n.i. at 10 μM |
>110 |
|
1 d |
5.23±0.48 |
58±12 |
|
1 e |
26.18±5.55 |
288±81 |
|
1 f |
n.i. at 10 μM |
>110 |
|
1 g |
30.50±0.92 |
335±61 |
|
negative controls |
2 a |
n.i. at 10 μM |
>110 |
2 c |
n.i. at 10 μM |
>110 |
|
2 f |
n.i. at 10 μM |
>110 |